GOLDMAN SACHS GROUP INC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$19,664,502
-35.3%
1,239,099
-23.1%
0.00%
-33.3%
Q2 2023$30,401,495
+257.6%
1,611,102
-27.2%
0.01%
+200.0%
Q1 2023$8,501,065
-35.2%
2,213,819
-16.2%
0.00%
-33.3%
Q4 2022$13,110,614
+157.7%
2,643,269
+148.3%
0.00%
+200.0%
Q3 2022$5,087,000
+33.4%
1,064,368
+25.6%
0.00%0.0%
Q2 2022$3,812,000
+17.8%
847,119
+24.6%
0.00%0.0%
Q1 2022$3,237,000
-56.9%
679,982
-32.8%
0.00%0.0%
Q4 2021$7,506,000
+1.8%
1,011,487
-22.2%
0.00%
-50.0%
Q3 2021$7,374,000
-17.6%
1,300,510
-4.2%
0.00%0.0%
Q2 2021$8,950,000
-57.4%
1,358,003
-47.7%
0.00%
-60.0%
Q1 2021$21,027,000
+24.4%
2,595,999
-0.9%
0.01%
+25.0%
Q4 2020$16,903,000
+402.6%
2,620,645
+180.5%
0.00%
+300.0%
Q3 2020$3,363,000
-57.5%
934,216
-45.7%
0.00%
-50.0%
Q2 2020$7,919,000
+133.0%
1,721,556
+72.7%
0.00%
+100.0%
Q1 2020$3,399,000
-24.2%
996,662
+13.5%
0.00%0.0%
Q4 2019$4,482,000
+336.0%
877,993
+106.6%
0.00%
Q3 2019$1,028,000
-58.2%
424,981
-62.5%
0.00%
-100.0%
Q2 2019$2,459,000
-41.7%
1,132,876
-27.2%
0.00%0.0%
Q1 2019$4,216,000
-28.2%
1,556,004
+27.2%
0.00%
-50.0%
Q4 2018$5,872,000
-52.7%
1,223,281
-6.6%
0.00%
-33.3%
Q3 2018$12,408,000
-21.9%
1,310,290
-19.7%
0.00%
-25.0%
Q2 2018$15,879,000
+48.8%
1,631,930
+60.9%
0.00%
+33.3%
Q1 2018$10,668,000
+340.3%
1,014,031
+168.2%
0.00%
Q4 2017$2,423,000
+0.6%
378,067
+20.1%
0.00%
Q3 2017$2,408,000
-47.9%
314,670
-51.6%
0.00%
-100.0%
Q2 2017$4,625,000
+90.6%
650,568
+3.7%
0.00%0.0%
Q1 2017$2,426,000
+84.5%
627,144
-2.7%
0.00%
Q4 2016$1,315,000
-27.2%
644,663
-4.3%
0.00%
-100.0%
Q3 2016$1,806,000
+8.3%
673,944
+24.5%
0.00%0.0%
Q2 2016$1,667,000
-34.1%
541,412
+82.4%
0.00%
Q1 2016$2,529,000
+77.3%
296,767
+182.4%
0.00%
Q4 2015$1,426,000
+7.9%
105,083
-23.6%
0.00%
Q3 2015$1,321,000
-67.3%
137,605
-51.0%
0.00%
-100.0%
Q2 2015$4,038,000
+35.8%
280,826
-15.5%
0.00%0.0%
Q1 2015$2,974,000
-1.4%
332,270
-32.8%
0.00%
Q4 2014$3,016,000
-27.8%
494,571
+25.4%
0.00%
-100.0%
Q3 2014$4,177,000
+228.4%
394,478
+267.6%
0.00%
Q2 2014$1,272,000
-28.8%
107,317
-10.3%
0.00%
Q1 2014$1,787,000
-11.2%
119,695
-12.7%
0.00%
Q4 2013$2,012,000
-27.0%
137,097
-15.4%
0.00%
-100.0%
Q3 2013$2,758,000
-17.7%
162,040
-19.8%
0.00%0.0%
Q2 2013$3,350,000
+42.1%
201,986
+9.3%
0.00%
Q4 2012$2,358,000
-46.4%
184,860
-38.7%
0.00%
-100.0%
Q3 2012$4,403,000
-40.0%
301,769
-31.1%
0.00%
-50.0%
Q2 2012$7,333,000
+253.4%
438,117
+203.7%
0.00%
Q1 2012$2,075,000144,2390.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders